Logo image of MANH

MANHATTAN ASSOCIATES INC (MANH) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:MANH - US5627501092 - Common Stock

176.05 USD
-0.6 (-0.34%)
Last: 11/26/2025, 8:00:00 PM
176.05 USD
0 (0%)
After Hours: 11/26/2025, 8:00:00 PM
Fundamental Rating

7

Taking everything into account, MANH scores 7 out of 10 in our fundamental rating. MANH was compared to 280 industry peers in the Software industry. Both the health and profitability get an excellent rating, making MANH a very profitable company, without any liquidiy or solvency issues. While showing a medium growth rate, MANH is valued expensive at the moment. These ratings would make MANH suitable for quality investing!


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

In the past year MANH was profitable.
In the past year MANH had a positive cash flow from operations.
Each year in the past 5 years MANH has been profitable.
MANH had a positive operating cash flow in each of the past 5 years.
MANH Yearly Net Income VS EBIT VS OCF VS FCFMANH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

1.2 Ratios

Looking at the Return On Assets, with a value of 28.10%, MANH belongs to the top of the industry, outperforming 97.50% of the companies in the same industry.
MANH has a Return On Equity of 69.86%. This is amongst the best in the industry. MANH outperforms 98.21% of its industry peers.
The Return On Invested Capital of MANH (61.70%) is better than 99.29% of its industry peers.
MANH had an Average Return On Invested Capital over the past 3 years of 55.23%. This is significantly above the industry average of 11.98%.
The last Return On Invested Capital (61.70%) for MANH is above the 3 year average (55.23%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 28.1%
ROE 69.86%
ROIC 61.7%
ROA(3y)25.89%
ROA(5y)23.38%
ROE(3y)64.44%
ROE(5y)55.45%
ROIC(3y)55.23%
ROIC(5y)47.73%
MANH Yearly ROA, ROE, ROICMANH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

1.3 Margins

With an excellent Profit Margin value of 20.25%, MANH belongs to the best of the industry, outperforming 84.29% of the companies in the same industry.
MANH's Profit Margin has improved in the last couple of years.
MANH's Operating Margin of 25.91% is amongst the best of the industry. MANH outperforms 90.00% of its industry peers.
MANH's Operating Margin has improved in the last couple of years.
MANH's Gross Margin of 56.54% is on the low side compared to the rest of the industry. MANH is outperformed by 65.36% of its industry peers.
In the last couple of years the Gross Margin of MANH has remained more or less at the same level.
Industry RankSector Rank
OM 25.91%
PM (TTM) 20.25%
GM 56.54%
OM growth 3Y7.44%
OM growth 5Y6%
PM growth 3Y7.95%
PM growth 5Y8.57%
GM growth 3Y-0.19%
GM growth 5Y0.34%
MANH Yearly Profit, Operating, Gross MarginsMANH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

9

2. Health

2.1 Basic Checks

MANH has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for MANH has been reduced compared to 1 year ago.
MANH has less shares outstanding than it did 5 years ago.
There is no outstanding debt for MANH. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MANH Yearly Shares OutstandingMANH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
MANH Yearly Total Debt VS Total AssetsMANH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

MANH has an Altman-Z score of 17.28. This indicates that MANH is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 17.28, MANH belongs to the best of the industry, outperforming 94.29% of the companies in the same industry.
There is no outstanding debt for MANH. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 17.28
ROIC/WACC5.62
WACC10.98%
MANH Yearly LT Debt VS Equity VS FCFMANH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.3 Liquidity

MANH has a Current Ratio of 1.31. This is a normal value and indicates that MANH is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.31, MANH is in line with its industry, outperforming 40.71% of the companies in the same industry.
MANH has a Quick Ratio of 1.31. This is a normal value and indicates that MANH is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of MANH (1.31) is comparable to the rest of the industry.
MANH does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.31
Quick Ratio 1.31
MANH Yearly Current Assets VS Current LiabilitesMANH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 9.59% over the past year.
Measured over the past years, MANH shows a very strong growth in Earnings Per Share. The EPS has been growing by 22.14% on average per year.
The Revenue has been growing slightly by 4.10% in the past year.
Measured over the past years, MANH shows a quite strong growth in Revenue. The Revenue has been growing by 11.02% on average per year.
EPS 1Y (TTM)9.59%
EPS 3Y28.48%
EPS 5Y22.14%
EPS Q2Q%0.74%
Revenue 1Y (TTM)4.1%
Revenue growth 3Y16.24%
Revenue growth 5Y11.02%
Sales Q2Q%3.42%

3.2 Future

The Earnings Per Share is expected to grow by 17.35% on average over the next years. This is quite good.
The Revenue is expected to grow by 7.70% on average over the next years.
EPS Next Y7.11%
EPS Next 2Y7.69%
EPS Next 3Y10.13%
EPS Next 5Y17.35%
Revenue Next Year3.58%
Revenue Next 2Y5.11%
Revenue Next 3Y6.4%
Revenue Next 5Y7.7%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MANH Yearly Revenue VS EstimatesMANH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B 2B
MANH Yearly EPS VS EstimatesMANH Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5 10 15

3

4. Valuation

4.1 Price/Earnings Ratio

MANH is valuated quite expensively with a Price/Earnings ratio of 35.00.
Compared to the rest of the industry, the Price/Earnings ratio of MANH is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 26.15, MANH is valued a bit more expensive.
Based on the Price/Forward Earnings ratio of 32.09, the valuation of MANH can be described as expensive.
The rest of the industry has a similar Price/Forward Earnings ratio as MANH.
When comparing the Price/Forward Earnings ratio of MANH to the average of the S&P500 Index (36.12), we can say MANH is valued inline with the index average.
Industry RankSector Rank
PE 35
Fwd PE 32.09
MANH Price Earnings VS Forward Price EarningsMANH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MANH is valued a bit cheaper than 67.14% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, MANH is valued a bit cheaper than 68.21% of the companies in the same industry.
Industry RankSector Rank
P/FCF 31.95
EV/EBITDA 36.71
MANH Per share dataMANH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates MANH does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of MANH may justify a higher PE ratio.
PEG (NY)4.92
PEG (5Y)1.58
EPS Next 2Y7.69%
EPS Next 3Y10.13%

0

5. Dividend

5.1 Amount

No dividends for MANH!.
Industry RankSector Rank
Dividend Yield N/A

MANHATTAN ASSOCIATES INC

NASDAQ:MANH (11/26/2025, 8:00:00 PM)

After market: 176.05 0 (0%)

176.05

-0.6 (-0.34%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)10-21 2025-10-21/amc
Earnings (Next)01-26 2026-01-26/amc
Inst Owners103.5%
Inst Owner Change2.01%
Ins Owners1.24%
Ins Owner Change-5.47%
Market Cap10.65B
Revenue(TTM)1.07B
Net Income(TTM)216.01M
Analysts81.05
Price Target230.44 (30.89%)
Short Float %3.23%
Short Ratio3.32
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.65%
Min EPS beat(2)13.36%
Max EPS beat(2)13.93%
EPS beat(4)4
Avg EPS beat(4)12.31%
Min EPS beat(4)8.28%
Max EPS beat(4)13.93%
EPS beat(8)8
Avg EPS beat(8)17.09%
EPS beat(12)12
Avg EPS beat(12)22.76%
EPS beat(16)16
Avg EPS beat(16)22.85%
Revenue beat(2)1
Avg Revenue beat(2)0.38%
Min Revenue beat(2)-0.51%
Max Revenue beat(2)1.26%
Revenue beat(4)2
Avg Revenue beat(4)0.07%
Min Revenue beat(4)-0.93%
Max Revenue beat(4)1.26%
Revenue beat(8)5
Avg Revenue beat(8)1.01%
Revenue beat(12)9
Avg Revenue beat(12)2.52%
Revenue beat(16)13
Avg Revenue beat(16)2.9%
PT rev (1m)-1.21%
PT rev (3m)-1.21%
EPS NQ rev (1m)-2.37%
EPS NQ rev (3m)-1.4%
EPS NY rev (1m)2.88%
EPS NY rev (3m)3.29%
Revenue NQ rev (1m)-0.69%
Revenue NQ rev (3m)-0.72%
Revenue NY rev (1m)0.09%
Revenue NY rev (3m)0.18%
Valuation
Industry RankSector Rank
PE 35
Fwd PE 32.09
P/S 9.98
P/FCF 31.95
P/OCF 30.67
P/B 34.43
P/tB 43.11
EV/EBITDA 36.71
EPS(TTM)5.03
EY2.86%
EPS(NY)5.49
Fwd EY3.12%
FCF(TTM)5.51
FCFY3.13%
OCF(TTM)5.74
OCFY3.26%
SpS17.64
BVpS5.11
TBVpS4.08
PEG (NY)4.92
PEG (5Y)1.58
Graham Number24.06
Profitability
Industry RankSector Rank
ROA 28.1%
ROE 69.86%
ROCE 75.03%
ROIC 61.7%
ROICexc 216.78%
ROICexgc 533.41%
OM 25.91%
PM (TTM) 20.25%
GM 56.54%
FCFM 31.23%
ROA(3y)25.89%
ROA(5y)23.38%
ROE(3y)64.44%
ROE(5y)55.45%
ROIC(3y)55.23%
ROIC(5y)47.73%
ROICexc(3y)379.42%
ROICexc(5y)338.92%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)67.16%
ROCE(5y)58.04%
ROICexgc growth 3YN/A
ROICexgc growth 5Y6.89%
ROICexc growth 3Y-16.71%
ROICexc growth 5Y14.68%
OM growth 3Y7.44%
OM growth 5Y6%
PM growth 3Y7.95%
PM growth 5Y8.57%
GM growth 3Y-0.19%
GM growth 5Y0.34%
F-Score7
Asset Turnover1.39
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 217.07%
Cap/Sales 1.31%
Interest Coverage 250
Cash Conversion 122.73%
Profit Quality 154.25%
Current Ratio 1.31
Quick Ratio 1.31
Altman-Z 17.28
F-Score7
WACC10.98%
ROIC/WACC5.62
Cap/Depr(3y)106.14%
Cap/Depr(5y)79.88%
Cap/Sales(3y)0.73%
Cap/Sales(5y)0.65%
Profit Quality(3y)134%
Profit Quality(5y)144.89%
High Growth Momentum
Growth
EPS 1Y (TTM)9.59%
EPS 3Y28.48%
EPS 5Y22.14%
EPS Q2Q%0.74%
EPS Next Y7.11%
EPS Next 2Y7.69%
EPS Next 3Y10.13%
EPS Next 5Y17.35%
Revenue 1Y (TTM)4.1%
Revenue growth 3Y16.24%
Revenue growth 5Y11.02%
Sales Q2Q%3.42%
Revenue Next Year3.58%
Revenue Next 2Y5.11%
Revenue Next 3Y6.4%
Revenue Next 5Y7.7%
EBIT growth 1Y6.41%
EBIT growth 3Y24.89%
EBIT growth 5Y17.68%
EBIT Next Year8.29%
EBIT Next 3Y8.86%
EBIT Next 5Y11.24%
FCF growth 1Y60.27%
FCF growth 3Y16.48%
FCF growth 5Y16.8%
OCF growth 1Y62.89%
OCF growth 3Y16.79%
OCF growth 5Y14.96%

MANHATTAN ASSOCIATES INC / MANH FAQ

Can you provide the ChartMill fundamental rating for MANHATTAN ASSOCIATES INC?

ChartMill assigns a fundamental rating of 7 / 10 to MANH.


What is the valuation status of MANHATTAN ASSOCIATES INC (MANH) stock?

ChartMill assigns a valuation rating of 3 / 10 to MANHATTAN ASSOCIATES INC (MANH). This can be considered as Overvalued.


Can you provide the profitability details for MANHATTAN ASSOCIATES INC?

MANHATTAN ASSOCIATES INC (MANH) has a profitability rating of 9 / 10.


Can you provide the PE and PB ratios for MANH stock?

The Price/Earnings (PE) ratio for MANHATTAN ASSOCIATES INC (MANH) is 35 and the Price/Book (PB) ratio is 34.43.


Can you provide the financial health for MANH stock?

The financial health rating of MANHATTAN ASSOCIATES INC (MANH) is 9 / 10.